We have previously reported that RBMS1 is upregulated in lung cancer and high RBMS1 expression is associated with poor prognosis in lung cancer patients.[15] To further explore the relationship between RBMS1 expression and clinicopathological features of lung cancer patients, forty tumor tissues were assigned to two groups (high or low RBMS1 expression) based on the immunohistochemistry (IHC) score. This evidence concerns the gene RBMS1 and lung carcinoma.